alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › automated-lumipulse

automated-lumipulse

3 studies tagged automated-lumipulse, dated 2024-03-07 to 2025-01-21. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Exploring the ability of plasma pTau217, pTau181 and beta-amyloid in mirroring cerebrospinal fluid biomarker profile of Mild Cognitive Impairment by the fully automated Lumipulse® platform 2025-01-21
  2. Clinical performance of the fully automated Lumipulse plasma p-tau217 assay in mild cognitive impairment and mild dementia 2025-01-01
  3. Exploring the potential of fully automated LUMIPULSE G plasma assays for detecting Alzheimer's disease pathology 2024-03-07

Studies

3 studies carry this tag.

Date range

2024 to 2025

Top journals

  • Alzheimer's & dementia (Amsterdam, Netherlands) 1
  • Alzheimer's research & therapy 1
  • Fluids and barriers of the CNS 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Exploring the ability of plasma pTau217, pTau181 and beta-amyloid in mirroring cerebrospinal fluid biomarker profile of Mild Cognitive Impairment by the fully automated Lumipulse® platform

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Fluids and barriers of the CNS 2025-01-21 Biomarkers

    Our results suggest that plasma biomarkers, and especially Aβ42/Aβ40 ratio and pTau217, are promising candidates for the early detection of AD pathology.

  2. Clinical performance of the fully automated Lumipulse plasma p-tau217 assay in mild cognitive impairment and mild dementia

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. Alzheimer's & dementia (Amsterdam, Netherlands) 2025-01-01 Biomarkers

    Our real-world data support the clinical use of fully automated plasma p-tau217 immunoassays, although further studies in more diverse cohorts are required.

  3. Exploring the potential of fully automated LUMIPULSE G plasma assays for detecting Alzheimer's disease pathology

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Alzheimer's research & therapy 2024-03-07 Biomarkers

    Our results show that the measurement of p-Tau181 in plasma has great potential as a non-invasive prognostic screening tool for implementation in a clinical setting.

All topic tags with their study counts